Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes

Circulation: Arrhythmia and Electrophysiology

Volumn 9, Issue 7, 2016, Pages

  Zorzi, Alessandro ^a   Marra, Martina Perazzolo ^a   Rigato, Ilaria ^a   De Lazzari, Manuel ^a   Susana, Angela ^a   Niero, Alice ^a   Pilichou, Kalliopi ^a   Migliore, Federico ^a   Rizzo, Stefania ^a   Giorgi, Benedetta ^a   De Conti, Giorgio ^b   Sarto, Patrizio ^c   Serratosa, Luis ^d   Patrizi, Giampiero ^e   De Maria, Elia ^e   Pelliccia, Antonio ^f   Basso, Cristina ^a   Schiavon, Maurizio ^g   Bauce, Barbara ^a   Iliceto, Sabino ^a   Thiene, Gaetano ^a   Corrado, Domenico ^a   more..

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Center for Sports Medicine   (Italy)

^d Hospital Universitario Quiron   (Spain)

^e Ospedale B Ramazzini   (Italy)

^f Italian National Olympic Committee   (Italy)

^g Center of Sports Medicine   (Italy)

Author keywords

athletes; cardiomyopathy; myocarditis; sport; sudden death

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ADULT; ARTICLE; ATHLETE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE WALL; HEART MUSCLE BIOPSY; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOKINESIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MOLECULAR PATHOLOGY; NONISCHEMIC LEFT VENTRICULAR SCAR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR; SUDDEN CARDIAC DEATH; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES;

ADOLESCENT; ADULT; ATHLETES; CASE-CONTROL STUDIES; CICATRIX; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; TACHYCARDIA, VENTRICULAR;

EID: 84978829517     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.116.004229     Document Type: Article

References (50)

1. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol. 2003; 42: 1959-1963
2. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006; 296: 1593-1601. doi: 10.1001/jama.296.13.1593
3. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988; 318: 129-133. doi: 10.1056/NEJM198801213180301
4. Maron BJ. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification. Cardiol Clin. 2007; 25: 399-414, vi. doi: 10.1016/j.ccl.2007.07.006
5. de Noronha SV, Sharma S, Papadakis M, Desai S, Whyte G, Sheppard MN. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study. Heart. 2009; 95: 1409-1414. doi: 10.1136/hrt.2009.168369
6. Harmon KG, Asif IM, Maleszewski JJ, Owens DS, Prutkin JM, Salerno JC, Zigman ML, Ellenbogen R, Rao AL, Ackerman MJ, Drezner JA. Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: a decade in review. Circulation. 2015; 132: 10-19. doi: 10.1161/CIRCULATIONAHA.115.015431
7. Brugada J, Brugada R, Brugada P. Channelopathies: a new category of diseases causing sudden death. Herz. 2007; 32: 185-191. doi: 10.1007/s00059-007-2976-1
8. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. 2001; 50: 399-408
9. Basso C, Carturan E, Pilichou K, Rizzo S, Corrado D, Thiene G. Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol. 2010; 19: 321-325. doi: 10.1016/j.carpath.2010.02.003
10. Galderisi M, Cardim N, D'Andrea A, Bruder O, Cosyns B, Davin L, Donal E, Edvardsen T, Freitas A, Habib G, Kitsiou A, Plein S, Petersen SE, Popescu BA, Schroeder S, Burgstahler C, Lancellotti P. The multimodality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16: 353. doi: 10.1093/ehjci/jeu323
11. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005; 26: 1461-1474. doi: 10.1093/eurheartj/ehi258
12. Perazzolo Marra M, Lima JA, Iliceto S. MRI in acute myocardial infarction. Eur Heart J. 2011; 32: 284-293. doi: 10.1093/eurheartj/ehq409
13. Vermes E, Carbone I, Friedrich MG, Merchant N. Patterns of myocardial late enhancement: typical and atypical features. Arch Cardiovasc Dis. 2012; 105: 300-308
14. Smaldone C, Pieroni M, Pelargonio G, Dello Russo A, Palmieri V, Bianco M, Gentile M, Crea F, Bellocci F, Zeppilli P. Left-dominant arrhythmogenic cardiomyopathy. Circ Arrhythm Electrophysiol. 2011; 4: e29-e32. doi: 10.1161/CIRCEP.111.962779
15. Nucifora G, Muser D, Masci PG, Barison A, Rebellato L, Piccoli G, Daleffe E, Toniolo M, Zanuttini D, Facchin D, Lombardi M, Proclemer A. Prevalence and prognostic value of concealed structural abnormalities in patients with apparently idiopathic ventricular arrhythmias of left versus right ventricular origin: a magnetic resonance imaging study. Circ Arrhythm Electrophysiol. 2014; 7: 456-462. doi: 10.1161/CIRCEP.113.001172
16. Schnell F, Claessen G, La Gerche A, Bogaert J, Lentz PA, Claus P, Mabo P, Carre F, Heidbuchel H. Subepicardial delayed gadolinium enhancement in asymptomatic athletes: Let sleeping dogs lie?. Br J Sports Med. 2016; 50: 111-117
17. Breuckmann F, Möhlenkamp S, Nassenstein K, Lehmann N, Ladd S, Schmermund A, Sievers B, Schlosser T, Jöckel KH, Heusch G, Erbel R, Barkhausen J. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology. 2009; 251: 50-57. doi: 10.1148/radiol.2511081118
18. Erz G, Mangold S, Franzen E, Claussen CD, Niess AM, Burgstahler C, Kramer U. Correlation between ECG abnormalities and cardiac parameters in highly trained asymptomatic male endurance athletes: evaluation using cardiac magnetic resonance imaging. Int J Cardiovasc Imaging. 2013; 29: 325-334. doi: 10.1007/s10554-012-0082-9
19. Franzen E, Mangold S, Erz G, Claussen CD, Niess AM, Kramer U, Burgstahler C. Comparison of morphological and functional adaptations of the heart in highly trained triathletes and long-distance runners using cardiac magnetic resonance imaging. Heart Vessels. 2013; 28: 626-631. doi: 10.1007/s00380-012-0289-7
20. La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, Macisaac AI, Heidbuchel H, Prior DL. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012; 33: 998-1006
21. Mangold S, Kramer U, Franzen E, Erz G, Bretschneider C, Seeger A, Claussen CD, Niess AM, Burgstahler C. Detection of cardiovascular disease in elite athletes using cardiac magnetic resonance imaging. Rofo. 2013; 185: 1167-1174. doi: 10.1055/s-0033-1350130
22. Möhlenkamp S, Lehmann N, Breuckmann F, Bröcker-Preuss M, Nassenstein K, Halle M, Budde T, Mann K, Barkhausen J, Heusch G, Jöckel KH, Erbel R; Marathon Study Investigators; Heinz Nixdorf Recall Study Investigators. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J. 2008; 29: 1903-1910. doi: 10.1093/eurheartj/ehn163
23. Mousavi N, Czarnecki A, Kumar K, Fallah-Rad N, Lytwyn M, Han SY, Francis A, Walker JR, Kirkpatrick ID, Neilan TG, Sharma S, Jassal DS. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol. 2009; 103: 1467-1472. doi: 10.1016/j. amjcard.2009.01.294
24. O'Hanlon R, Wilson M, Wage R, Smith G, Alpendurada FD, Wong J, Dahl A, Oxborough D, Godfrey R, Sharma S, Roughton M, George K, Pennell DJ, Whyte G, Prasad SK. Troponin release following endurance exercise: is inflammation the cause?. A cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2010; 12: 38. doi: 10.1186/1532-429X-12-38
25. Oomah SR, Mousavi N, Bhullar N, Kumar K, Walker JR, Lytwyn M, Colish J, Wassef A, Kirkpatrick ID, Sharma S, Jassal DS. The role of three-dimensional echocardiography in the assessment of right ventricular dysfunction after a half marathon: comparison with cardiac magnetic resonance imaging. J Am Soc Echocardiogr. 2011; 24: 207-213. doi: 10.1016/j. echo.2010.10.012
26. Wilson M, O'Hanlon R, Prasad S, Deighan A, Macmillan P, Oxborough D, Godfrey R, Smith G, Maceira A, Sharma S, George K, Whyte G. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol (1985). 2011; 110: 1622-1626. doi: 10.1152/japplphysiol.01280.2010
27. Breithardt G, Cain ME, el-Sherif N, Flowers NC, Hombach V, Janse M, Simson MB, Steinbeck G. Standards for analysis of ventricular late potentials using high-resolution or signal-Averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Circulation. 1991; 83: 1481-1488
28. Whyte G, Sheppard M, George K, Shave R, Wilson M, Prasad S, O'Hanlon R, Sharma S. Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause?. Br J Sports Med. 2008; 42: 304-305. doi: 10.1136/bjsm.2007.038158
29. Pilichou K, Mancini M, Rigato I, Lazzarini E, Giorgi B, Carturan E, Bauce B, d'Amati G, Marra MP, Basso C. Nonischemic left ventricular scar: sporadic or familial?. Screen the genes, scan the mutation carriers. Circulation. 2014; 130: e180-e182. doi: 10.1161/CIRCULATIONAHA.114.012515
30. d'Amati G, De Caterina R, Basso C. Sudden cardiac death in an Italian competitive athlete: pre-participation screening and cardiovascular emergency care are both essential. Int J Cardiol. 2016; 206: 84-86. doi: 10.1016/j.ijcard.2016.01.011
31. de Jong S, van Veen TA, van Rijen HV, de Bakker JM. Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol. 2011; 57: 630-638. doi: 10.1097/FJC.0b013e318207a35f.
32. Rademakers FE, Rogers WJ, Guier WH, Hutchins GM, Siu CO, Weisfeldt ML, Weiss JL, Shapiro EP. Relation of regional cross-fiber shortening to wall thickening in the intact heart. Three-dimensional strain analysis by NMR tagging. Circulation. 1994; 89: 1174-1182
33. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53: 1475-1487. doi: 10.1016/j.jacc.2009.02.007
34. Friedrich MG, Marcotte F. Cardiac magnetic resonance assessment of myocarditis. Circ Cardiovasc Imaging. 2013; 6: 833-839
35. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34: 2636-48, 2648a. doi: 10.1093/eurheartj/eht210
36. Froehlich W, Bogun FM, Crawford TC. Cardiac sarcoidosis. Circulation. 2015; 132: e137-e138. doi: 10.1161/CIRCULATIONAHA. 114.013308
37. Kühl U, Noutsias M, Seeberg B, Schultheiss HP. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart. 1996; 75: 295-300
38. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?. Circulation. 1996; 94: 983-991
39. Thiene G, Corrado D, Nava A, Rossi L, Poletti A, Boffa GM, Daliento L, Pennelli N. Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology?. Eur Heart J. 1991; 12(suppl D): 22-25
40. Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, Panhuyzen-Goedkoop NM, Pigozzi F, Schänzer W, Vanhees L; ESC Study Group of Sports Cardiology. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil. 2006; 13: 687-694. doi: 10.1097/01.hjr.0000224482.95597.7a.
41. Shephard RJ, Shek PN. Potential impact of physical activity and sport on the immune system-A brief review. Br J Sports Med. 1994; 28: 247-255
42. Marra MP, Leoni L, Bauce B, Corbetti F, Zorzi A, Migliore F, Silvano M, Rigato I, Tona F, Tarantini G, Cacciavillani L, Basso C, Buja G, Thiene G, Iliceto S, Corrado D. Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol. 2012; 5: 91-100. doi: 10.1161/CIRCEP.111.964635
43. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009; 373: 1289-1300. doi: 10.1016/S0140-6736(09)60256-7
44. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D, Pennell DJ, McKenna WJ. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol. 2008; 52: 2175-2187. doi: 10.1016/j.jacc.2008.09.019
45. Shehata ML, Lossnitzer D, Skrok J, Boyce D, Lechtzin N, Mathai SC, Girgis RE, Osman N, Lima JA, Bluemke DA, Hassoun PM, Vogel-Claussen J. Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. AJR Am J Roentgenol. 2011; 196: 87-94. doi: 10.2214/ajr.196.5-supplement.0a87
46. La Gerche A. Can intense endurance exercise cause myocardial damage and fibrosis?. Curr Sports Med Rep. 2013; 12: 63-69. doi: 10.1249/JSR.0b013e318287488a.
47. Chan RH, Maron BJ, Olivotto I, Assenza GE, Haas TS, Lesser JR, Gruner C, Crean AM, Rakowski H, Rowin E, Udelson J, Lombardi M, Tomberli B, Spirito P, Formisano F, Marra MP, Biagini E, Autore C, Manning WJ, Appelbaum E, Roberts WC, Basso C, Maron MS. Significance of late gadolinium enhancement at right ventricular attachment to ventricular septum in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2015; 116: 436-441. doi: 10.1016/j.amjcard. 2015.04.060
48. Martherus R, Jain R, Takagi K, Mendsaikhan U, Turdi S, Osinska H, James JF, Kramer K, Purevjav E, Towbin JA. Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/β-catenin signaling. Am J Physiol Heart Circ Physiol. 2016; 310: H174-H187. doi: 10.1152/ajpheart.00295.2015
49. Corrado D, Zorzi A. Arrhythmogenic right ventricular cardiomyopathy and sports activity. Eur Heart J. 2015; 36: 1708-1710. doi: 10.1093/eurheartj/ehv183
50. Oloriz T, Silberbauer J, Maccabelli G, Mizuno H, Baratto F, Kirubakaran S, Vergara P, Bisceglia C, Santagostino G, Marzi A, Sora N, Roque C, Guarracini F, Tsiachris D, Radinovic A, Cireddu M, Sala S, Gulletta S, Paglino G, Mazzone P, Trevisi N, Della Bella P. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types. Circ Arrhythm Electrophysiol. 2014; 7: 414-423. doi: 10.1161/CIRCEP.11